The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 17 August 2004, www.theannals.com, DOI 10.1345/aph.1E153.
 The Annals of Pharmacotherapy: Vol. 38, No. 11, pp. 1942-1945. DOI 10.1345/aph.1E153
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prescott, W. A
Right arrow Articles by Btaiche, I. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prescott, W. A, Jr
Right arrow Articles by Btaiche, I. F

DRUG INFORMATION ROUNDS

Sincalide in Patients with Parenteral Nutrition–Associated Gallbladder Disease

William A Prescott, Jr, PharmD

Clinical Instructor, College of Pharmacy, University of Michigan, Ann Arbor, MI; Specialty Resident in Pediatric Pharmacotherapy, University of Michigan Hospitals and Health Centers

Imad F Btaiche, PharmD BCNSP

Clinical Assistant Professor, College of Pharmacy, University of Michigan; Clinical Pharmacist, University of Michigan Hospitals and Health Centers

Reprints: Imad F Btaiche PharmD BCNSP, Department of Pharmacy Services, University of Michigan Hospitals and Health Centers, UH2D301 Box 0008, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-0008, fax 734/936-7027, imadb{at}umich.edu

OBJECTIVE: To review the role of sincalide in treating and preventing parenteral nutrition (PN)–associated gallbladder disease.

DATA SOURCES: A MEDLINE (1996–March 2004) search was performed using the key terms cholecystokinin, sincalide, parenteral nutrition, cholelithiasis, cholestasis, and sludge.

DATA SYNTHESIS: Five human studies investigated the safety and efficacy of sincalide in patients with PN-associated gallbladder disease. Sincalide at intravenous doses of 0.04 µg/kg 3 times daily increased bile flow and improved serum bilirubin levels. However, patients with advanced liver disease did not respond to sincalide therapy. Long-term follow-up data on sincalide effects on liver disease progression are not yet available.

CONCLUSIONS: Sincalide improved the signs of cholestasis. However, its long-term effects in preventing and treating PN-associated gallbladder disease remain unknown and its routine use for this indication cannot be recommended at this time.

Key Words: gall bladder disease, parenteral nutrition, sincalide

Published Online, August 17, 2004. www.theannals.com, DOI 10.1345/aph.1E153




homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.